Skip to main content
Deutsches Ärzteblatt International logoLink to Deutsches Ärzteblatt International
letter
. 2023 Mar 17;120(11):193–194. doi: 10.3238/arztebl.m2022.0330

In Reply

Christian Rauschert *
PMCID: PMC10213476  PMID: 37222039

Epidemiological studies have satisfactorily confirmed a dose–response relation between the consumed amount of tobacco or alcohol and the risk of illness. Research has shown that no safe threshold exists regarding tobacco consumption, but that only complete abstinence is considered as safe regarding health (1). Even moderate amounts of alcohol can increase the risk for a range of severe disease (2).

The problematic consumption (indication of dependence) of tobacco and alcohol as an independent diagnosis requiring treatment needs to be distinguished from the risk of subsequent disease because of one’s own substance consumption or external extraneous exposure (for example, passive smoking). Furthermore, the criteria for diagnosing problematic consumption of tobacco or alcohol (misuse or dependence) are not based on the amount consumed but on the somatic, psychological, and negative social consequences of substance use.

Using amounts consumed as diagnostic criteria is still the subject of controversial discussion (3). Among others, using amounts consumed would have the advantage of a continuous measure.

For the diagnosis, differentiating between problematic and non-problematic consumption is highly relevant as the modality of further treatment is based crucially on whether and which diagnosis exists. The treatment plan for a person with signs of alcohol dependence differs from that of a person with increased disease risk who does not show any signs of dependence.

Independently of the definition of problematic or non-problematic consumption—or dependence or otherwise—the implementation of preventive measures aiming to reduce consumption is of great importance, so as to reduce the hazards and risk of tobacco and alcohol consumption in as sustained a manner as possible.

Footnotes

Conflict of interest statement The authors of all correspondence declare that no conflict of interest exists.

References

  • 1.Hackshaw A, Morris JK, Boniface S, Tang JL, Milenković D. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018;360 j5855. doi: 10.1136/bmj.j5855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Rehm, J, Baliunas D, Borges GL, et al. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction. 2010;105:817–843. doi: 10.1111/j.1360-0443.2010.02899.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Rehm J, Marmet S, Anderson P, et al. Defining substance use disorders: do we really need more than heavy use? Alcohol Alcohol. 2013;48,:633–640. doi: 10.1093/alcalc/agt127. [DOI] [PubMed] [Google Scholar]
  • 4.Rauschert C, Möckl J, Seitz NN, Wilms N, Olderbak S, Kraus L. The use of psychoactive substances in Germany—findings from the Epidemiological Survey of Substance Abuse 2021. Dtsch Arztebl Int. 2022;119:527–534. doi: 10.3238/arztebl.m2022.0244. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Deutsches Ärzteblatt International are provided here courtesy of Deutscher Arzte-Verlag GmbH

RESOURCES